Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L0LR
|
||||
Former ID |
DIB015375
|
||||
Drug Name |
UCL-67022
|
||||
Synonyms |
HDAC inhibitor (multiple myeloma), ST Barts/UCL
|
||||
Indication | Multiple myeloma [ICD9: 203; ICD10:C90] | Investigative | [543662] | ||
Company |
University College London
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1cccc(c1)NC(=O)C(CCCCCC(=O)NO)C(=O)Nc1ccccc1
|
||||
Target and Pathway | |||||
Target(s) | Histone deacetylase 6 | Target Info | Inhibitor | [543662] | |
KEGG Pathway | Alcoholism | ||||
Viral carcinogenesis | |||||
Pathway Interaction Database | Signaling events mediated by HDAC Class II | ||||
Signaling events mediated by HDAC Class I | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.